Lu S - Search Results

1

FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance.

Wang Z, Cai J, Cheng J, Yang W, Zhu Y, Li H, Lu T, Chen Y, Lu S. Wang Z, et al. Among authors: lu s, lu t. J Med Chem. 2021 Mar 25;64(6):2878-2900. doi: 10.1021/acs.jmedchem.0c01851. Epub 2021 Mar 10. J Med Chem. 2021. PMID: 33719439 Review.

2

Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.

Chen XM, Lu T, Lu S, Li HF, Yuan HL, Ran T, Liu HC, Chen YD. Chen XM, et al. Among authors: lu s, lu t. J Mol Model. 2010 Jul;16(7):1195-204. doi: 10.1007/s00894-009-0630-y. Epub 2009 Dec 18. J Mol Model. 2010. PMID: 20020310

3

Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.

Zhu Y, Li HF, Lu S, Zheng YX, Wu Z, Tang WF, Zhou X, Lu T. Zhu Y, et al. Among authors: lu s, lu t. Eur J Med Chem. 2010 May;45(5):1777-91. doi: 10.1016/j.ejmech.2010.01.010. Epub 2010 Jan 28. Eur J Med Chem. 2010. PMID: 20153566

4

Novel strategy for three-dimensional fragment-based lead discovery.

Yuan H, Lu T, Ran T, Liu H, Lu S, Tai W, Leng Y, Zhang W, Wang J, Chen Y. Yuan H, et al. Among authors: lu s, lu t. J Chem Inf Model. 2011 Apr 25;51(4):959-74. doi: 10.1021/ci200003c. Epub 2011 Mar 25. J Chem Inf Model. 2011. PMID: 21438547

5

Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors.

Tai W, Lu T, Yuan H, Wang F, Liu H, Lu S, Leng Y, Zhang W, Jiang Y, Chen Y. Tai W, et al. Among authors: lu s, lu t. J Mol Model. 2012 Jul;18(7):3087-100. doi: 10.1007/s00894-011-1328-5. Epub 2011 Dec 28. J Mol Model. 2012. PMID: 22203475

6

Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.

Lu S, Liu HC, Chen YD, Yuan HL, Sun SL, Gao YP, Yang P, Zhang L, Lu T. Lu S, et al. Among authors: lu t. Int J Mol Sci. 2011;12(12):8713-39. doi: 10.3390/ijms12128713. Epub 2011 Dec 1. Int J Mol Sci. 2011. PMID: 22272100 Free PMC article.

7

Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening.

Lu S, Sun SL, Liu HC, Chen YD, Yuan HL, Gao YP, Yang P, Lu T. Lu S, et al. Among authors: lu t. Chem Biol Drug Des. 2012 Aug;80(2):328-39. doi: 10.1111/j.1747-0285.2012.01412.x. Epub 2012 Jun 8. Chem Biol Drug Des. 2012. PMID: 22583481

8

Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype.

Lu Q, Lu S, Gao X, Luo Y, Tong B, Wei Z, Lu T, Xia Y, Chou G, Wang Z, Dai Y. Lu Q, et al. Among authors: lu s, lu t. Exp Biol Med (Maywood). 2012 Aug;237(8):919-32. doi: 10.1258/ebm.2012.011416. Epub 2012 Aug 8. Exp Biol Med (Maywood). 2012. PMID: 22875342

9

QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.

Leng Y, Lu T, Yuan HL, Liu HC, Lu S, Zhang WW, Jiang YL, Chen YD. Leng Y, et al. Among authors: lu s, lu t. SAR QSAR Environ Res. 2012 Oct;23(7-8):705-30. doi: 10.1080/1062936X.2012.719541. Epub 2012 Sep 13. SAR QSAR Environ Res. 2012. PMID: 22971111

10

De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET prediction.

Zhang Y, Liu H, Jiao Y, Yuan H, Wang F, Lu S, Yao S, Ke Z, Tai W, Jiang Y, Chen Y, Lu T. Zhang Y, et al. Among authors: lu s, lu t. Mol Divers. 2012 Nov;16(4):787-802. doi: 10.1007/s11030-012-9405-y. Epub 2012 Oct 23. Mol Divers. 2012. PMID: 23090418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,011 results

Search Page